493 related articles for article (PubMed ID: 36839978)
1. Current Advances in Lipid Nanosystems Intended for Topical and Transdermal Drug Delivery Applications.
Akombaetwa N; Ilangala AB; Thom L; Memvanga PB; Witika BA; Buya AB
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839978
[TBL] [Abstract][Full Text] [Related]
2. Overcoming skin barriers through advanced transdermal drug delivery approaches.
Phatale V; Vaiphei KK; Jha S; Patil D; Agrawal M; Alexander A
J Control Release; 2022 Nov; 351():361-380. PubMed ID: 36169040
[TBL] [Abstract][Full Text] [Related]
3. Advancement of Lipid-Based Nanocarriers and Combination Application with Physical Penetration Technique.
Yang M; Gu Y; Tang X; Wang T; Liu J
Curr Drug Deliv; 2019; 16(4):312-324. PubMed ID: 30657039
[TBL] [Abstract][Full Text] [Related]
4. Topical Drug Delivery of Anti-infectives Employing Lipid-Based Nanocarriers: Dermatokinetics as an Important Tool.
Thakur K; Sharma G; Singh B; Katare OP
Curr Pharm Des; 2018; 24(43):5108-5128. PubMed ID: 30657036
[TBL] [Abstract][Full Text] [Related]
5. (Phospho)lipid-based Nanosystems for Skin Administration.
Vanić Z; Holæter AM; Skalko-Basnet N
Curr Pharm Des; 2015; 21(29):4174-92. PubMed ID: 26323431
[TBL] [Abstract][Full Text] [Related]
6. Delving Deeper into Dermal and Transdermal Drug Delivery: Factors and Mechanisms Associated with Nanocarrier-mediated Strategies.
Manikkath J; Sumathy TK; Manikkath A; Mutalik S
Curr Pharm Des; 2018; 24(27):3210-3222. PubMed ID: 30246632
[TBL] [Abstract][Full Text] [Related]
7. Topical Nano and Microemulsions for Skin Delivery.
Nastiti CMRR; Ponto T; Abd E; Grice JE; Benson HAE; Roberts MS
Pharmaceutics; 2017 Sep; 9(4):. PubMed ID: 28934172
[TBL] [Abstract][Full Text] [Related]
8. Permeation enhancers in transdermal drug delivery: benefits and limitations.
Kováčik A; Kopečná M; Vávrová K
Expert Opin Drug Deliv; 2020 Feb; 17(2):145-155. PubMed ID: 31910342
[No Abstract] [Full Text] [Related]
9. Solid Lipid Nanoparticles for Topical Drug Delivery: Mechanisms, Dosage Form Perspectives, and Translational Status.
Liu M; Wen J; Sharma M
Curr Pharm Des; 2020; 26(27):3203-3217. PubMed ID: 32452322
[TBL] [Abstract][Full Text] [Related]
10. The Contest of Nanoparticles: Searching for the Most Effective Topical Delivery of Corticosteroids.
Kalvodová A; Dvořáková K; Petrová E; Michniak-Kohn BB; Zbytovská J
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839836
[TBL] [Abstract][Full Text] [Related]
11. Biomimetic Lipid-Based Nanosystems for Enhanced Dermal Delivery of Drugs and Bioactive Agents.
Kotla NG; Chandrasekar B; Rooney P; Sivaraman G; Larrañaga A; Krishna KV; Pandit A; Rochev Y
ACS Biomater Sci Eng; 2017 Jul; 3(7):1262-1272. PubMed ID: 33440514
[TBL] [Abstract][Full Text] [Related]
12. Omega-3- and Resveratrol-Loaded Lipid Nanosystems for Potential Use as Topical Formulations in Autoimmune, Inflammatory, and Cancerous Skin Diseases.
Caldas AR; Catita J; Machado R; Ribeiro A; Cerqueira F; Horta B; Medeiros R; Lúcio M; Lopes CM
Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452163
[TBL] [Abstract][Full Text] [Related]
13. Design of a transdermal formulation containing raloxifene nanoparticles for osteoporosis treatment.
Nagai N; Ogata F; Otake H; Nakazawa Y; Kawasaki N
Int J Nanomedicine; 2018; 13():5215-5229. PubMed ID: 30233182
[TBL] [Abstract][Full Text] [Related]
14. Lipid vesicles: A versatile drug delivery platform for dermal and transdermal applications.
Chacko IA; Ghate VM; Dsouza L; Lewis SA
Colloids Surf B Biointerfaces; 2020 Nov; 195():111262. PubMed ID: 32736123
[TBL] [Abstract][Full Text] [Related]
15. Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles.
Elnaggar YS; El-Massik MA; Abdallah OY
Int J Nanomedicine; 2011; 6():3195-205. PubMed ID: 22238508
[TBL] [Abstract][Full Text] [Related]
16. Applications and limitations of lipid nanoparticles in dermal and transdermal drug delivery via the follicular route.
Lauterbach A; Müller-Goymann CC
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):152-63. PubMed ID: 26144664
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in Lipid-Based Vesicles and Particulate Carriers for Topical and Transdermal Application.
Jain S; Patel N; Shah MK; Khatri P; Vora N
J Pharm Sci; 2017 Feb; 106(2):423-445. PubMed ID: 27865609
[TBL] [Abstract][Full Text] [Related]
18. The Factors Determining the Skin Penetration and Cellular Uptake of Nanocarriers: New Hope for Clinical Development.
Farjami A; Salatin S; Jafari S; Mahmoudian M; Jelvehgari M
Curr Pharm Des; 2021; 27(42):4315-4329. PubMed ID: 34779364
[TBL] [Abstract][Full Text] [Related]
19. Exploring the Promising Potential of High Permeation Vesicle-Mediated Localized Transdermal Delivery of Docetaxel in Breast Cancer To Overcome the Limitations of Systemic Chemotherapy.
Bathara M; Date T; Chaudhari D; Ghadi R; Kuche K; Jain S
Mol Pharm; 2020 Jul; 17(7):2473-2486. PubMed ID: 32496783
[TBL] [Abstract][Full Text] [Related]
20. Physicochemical and biopharmaceutical aspects influencing skin permeation and role of SLN and NLC for skin drug delivery.
Souto EB; Fangueiro JF; Fernandes AR; Cano A; Sanchez-Lopez E; Garcia ML; Severino P; Paganelli MO; Chaud MV; Silva AM
Heliyon; 2022 Feb; 8(2):e08938. PubMed ID: 35198788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
